Biovica International AB (OSTO:BIOVIC B)
kr 2.6 0.2 (8.33%) Market Cap: 218.54 Mil Enterprise Value: 121.52 Mil PE Ratio: 0 PB Ratio: 1.61 GF Score: 37/100

Q3 2022 Biovica International AB Earnings Call Transcript

Mar 15, 2022 / 02:00PM GMT
Release Date Price: kr27.85 (+4.84%)
Operator

Welcome to the Biovica International Q3 Interim Reports FY '21/'22. (Operator Instructions)

I'll now hand the floor to CEO, Anders Rylander. Please begin your meeting.

Anders Rylander;publ;CEO;Director
Biovica International AB

()-&

Thank you very much for that, Mark, and welcome, everyone, to this Q3 Interim Report presentation. So if we move into the second slide, we have the presenters of today. It's me, Anders Rylander, CEO of the company. And together with me, I have EVP and CFO, Cecilia Driving; and Warren Cresswell, President of Biovica Americas, they will also support me and makes part of this presentation.

So if we move forward to the third slide, you have the agenda for today. So I will start to make a very short introduction about the company and our product, then we will quickly move into the quarter, the report and the highlights and then we'll dive in a little bit deeper to topics that we've selected, the FDA status and give an update on that.

And Warren will go

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot